Galderma Sued Over Patent Sale Agreement For Skin Drug
Five former shareholders of a pharmaceutical company that held patent rights for skin medication Brimonidine have sued current rights holder Galderma Laboratories LP in Pennsylvania court, arguing the company refuses to...To view the full article, register now.
Already a subscriber? Click here to view full article